(Q44325671)

2 December 2017

title

Systemic availability and lung deposition of budesonide via three different nebulizers in adults (English)

1 reference

2 December 2017

Kerstin Dahlström

1

1 reference

2 December 2017

Lars Thorsson

series ordinal

2

1 reference

2 December 2017

Per Larsson

series ordinal

3

1 reference

2 December 2017

Kurt Nikander

series ordinal

4

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Annals of Allergy, Asthma & Immunology

2 December 2017

published in

1 reference

2 December 2017

volume

90

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

226-232

1 reference

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Systemic availability and pharmacokinetics of nebulised budesonide in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Lung deposition from four nebulizers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

New perspectives on inhaled drug delivery and systemic bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

The influence of lung deposition on clinical response.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Impact of constant and breath-synchronized nebulization on inhaled mass of nebulized budesonide in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

Evaluation of pulsed and breath-synchronized nebulization of budesonide as a means of reducing nebulizer wastage of drug

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962146-1

7 January 2021

10.1016/S1081-1206(10)62146-1

Identifiers

DOI

1 reference

2 December 2017

1 reference